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BACKGROUND

RESULTS

Glucose <54 mg/dL was recently defined as Clinically Significant
Hypoglycemia (CSH, American Diabetes Association, Standards of Medical
Care in Diabetes, 2017). In January 2018, our hospitals instituted a callback policy for inpatient CSH from the central laboratory, and instituted a
new nursing procedure for response to CSH. We examined whether the
new policies had affected the incidence rate of low glucose critical values
(CRITICAL, <40 mg/dL) among POCT glucose measurements. This was
investigated for two hospitals within our system: A, a 950-bed academic
medical center hospital, and B, a 200-bed community hospital.

METHODS
POCT glucose results (Roche Accuchek) for two 12 week intervals before
(PRE) and after (POST) the policy change date were obtained from the
POCT reporting system for both hospitals. Incidence quotients (Q, defined
as results either in category of CRITICAL or CSH per total number of
glucose results in interval) were tabulated by Excel spreadsheet for PRE
and POST dataset analyses.

Analyses were performed for four datasets (table below). The most
important statistic is a comparison of the number of unique patients
experiencing one or more CRITICALS in intervals PRE and POST.
Q among unique patients having one or more CRITICALS was
significantly increased in POST for hospital A.

CONCLUSIONS
After adoption of new CSH policies, the incidence quotient (Q) for
CRITICAL glucoses by POCT increased significantly at hospitals A
and B by 26% and 28%, respectively (p<0.01). Q for unique patients
having one or more CRITICALS increased at hospital A by 17%
(p<0.01) and at hospital B by 7% (not significant). Presumably, the
increases reflect increased awareness of circumstances in which
CSH may develop, leading to a significantly higher selection rate for
measurement of CRITICAL glucoses by POCT. POCT for glucose
clearly plays an important role in response to CSH at both hospitals.

Hospital A
950-bed academic medical center hospital

Total

Critical

PRE

POST

n= 76,745
(6,450 patients)

n= 78,838
(6,507 patients)

n= 169
n= 218
(97 patients)
(116 patients)
Q (Criticals): 2.20E-3 Q (Criticals): 2.77E-3

Comments:
POST
compared to
PRE

Hospital B
200-bed community hospital
Comments:
POST
compared to
PRE

PRE

POST

n= 16,954
(2,434 patients)

n= 19,779
(2,589 patients)

Q increased
by 26%

n= 26
(16 patients)
Q (Criticals): 1.53E-3

n= 39
(20 patients)
Q (Criticals): 1.97E-3

Q increased
by 28%

n= 110
(54 patients)
Q (CSH): 5.56E-3

Q decreased
by 7%

n= 20
Q (Unique): 1.01E-3

Q increased
by 7%

CSH

n= 613
(318 patients)
Q (CSH): 7.99E-3

n= 769
(328 patients)
Q (CSH): 9.75E-3

Q increased
by 22%

n= 101
(59 patients)
Q (CSH): 5.95E-3

Unique patients
(one or more
critical results)

n= 97
Q (Unique): 1.26E-3

n= 116
Q (Unique): 1.47E-3

Q increased
by 17%

n= 16
Q (Unique): 0.94E-3
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